KLRK1 and prostate cancer: The relation of high levels of sMICB with poor prognosis could be explained because the shedding of sMICB in the bloodstream causes the ineffectiveness of NKG2D-mediated immunity in epithelial cancer including lung, ovarian, colon, breast, neuroblastoma, melanoma, and prostate cancer [74].